Key result
Antidepressant use is linked to ~278% higher insulin initiation in patients with T2D and depression.
Why the study?
To investigate the association between antidepressant prescribing and the rate of insulin initiation in individuals with type 2 diabetes.
Does antidepressant prescribing increase the rate of insulin initiation in individuals with comorbid depression and type 2 diabetes?
Case-Control (n=55,314)
Does antidepressant prescribing increase the rate of insulin initiation in individuals with comorbid depression and type 2 diabetes?
Relative Risk: 3.78 (95% CI 3.53–4.04)
Antidepressant prescribing is strongly associated with insulin initiation in patients with type 2 diabetes and depression, though this may reflect depression severity rather than a direct drug effect.
May prompt closer glycemic monitoring in T2D with depression; leaves open confounding by severity.
AIMS: To investigate the association between antidepressant prescribing and the rate of insulin initiation in type 2 diabetes. METHODS: Using UK primary care records we completed a nested-case control study in a individuals with comorbid depression and type 2 diabetes. Cases were defined as individuals initiating insulin, controls were individuals remaining on oral antidiabetic medication. We used conditional logistic regression to estimate incident rate ratios (IRR) and the 95% confidence intervals (CI) for the association between antidepressant prescribing and initiating insulin. We adjusted for demographic characteristics, comorbidities, health service and previous medication use. RESULTS: We included 11,862 cases who initiated insulin, and 43,452 controls. Increased rates of insulin initiation were associated with any antidepressant prescription (IRR 3.78, 95% CI 3.53-4.04), longer (24+ months) durations of antidepressant treatment (IRR 5.61, 95% CI 5.23-6.03), and higher numbers (3+) of different antidepressant agents prescribed (IRR 5.72, 95% CI 5.25-6.24). There was no difference between recent and non-recent antidepressant prescriptions, or between different antidepressant agents. CONCLUSIONS: Antidepressant prescribing was highly associated with the initiation of insulin therapy. However, this may not indicate a direct causal effect of the antidepressant medication itself, and may be a marker of more severe depression influencing diabetic control.
No takes yet. Share an insight, caveat, or question.
Jeffery et al. (2023) conducted a case-control in Comorbid depression and type 2 diabetes (n=55,314). Antidepressant prescribing vs. No antidepressant prescription was evaluated on Initiation of insulin therapy (IRR 3.78, 95% CI 3.53-4.04). Antidepressant prescribing was associated with a significantly increased rate of insulin initiation among patients with comorbid depression and type 2 diabetes (IRR 3.78; 95% CI 3.53-4.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: